Enlyte Celebrates Nine Winners of the 2026 Heart of Case Management Awards
New behavioral health category recognizes case management excellence in mental healthSAN DIEGO, Oct. 12, 2026 /PRNewswire/ -- Enlyte has named a...
Brain
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1 -...
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines...
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines...
NurExone Advances Optic Nerve Injury Program Toward Larger-Animal Study, Following Positive Preclinical Results
Preclinical Results at Sheba Medical Center Demonstrate Retinal Recovery with NurExone’s Exosome-based Lead CandidateTORONTO and HAIFA, Israel, Oct. 09, 2026...
New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia
Research presented at ISFTD 2026 connects measurements from the living brain with disease patterns confirmed through postmortem analysis Mapping cortical...
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
Fort Lee, NJ, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
In HelloNation, Audiology Expert Dr. Nicole Anzalone Explains What to Expect During Vestibular Testing
The article explains how different tests evaluate the inner ear, eye movements, and balance function to help investigate dizziness and...
Alpheus Medical Opens Enrollment in New Clinical Trial for Butterfly Glioblastoma
The study will evaluate PoMA™ therapy, Alpheus' drug-led, tumor-selective treatment approach, in patients with butterfly glioblastoma, a particularly aggressive form...
Summus Announces Independent Analysis Validating Modeled Medical Cost Savings Across Complex Care Journeys
Independent analysis finds $30,474 in modeled median savings per engaged member, per journey through changed treatment pathsFindings remained consistent across...
Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update
Calgary, Alberta--(Newsfile Corp. - October 7, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
Study on trauma-informed online learning and GenAI support for student persistence published by University of Phoenix researchers
Peer-reviewed study of 45 online working adult undergraduates introduces a model linking course design, psychological safety and guided AI use. PHOENIX,...
AIAS+ 2026 Brings Leading Scientists to San Francisco to Explore How AI Is Changing Scientific Discovery
Chen Institute symposium Nov. 5–7 will feature newly named 2026 Nobel Laureate Karl Deisseroth alongside Terence Tao, Jeffrey Ullman, James...
Study on trauma-informed online learning and GenAI support for student persistence published by University of Phoenix researchers
Peer-reviewed study of 45 online working adult undergraduates introduces a model linking course design, psychological safety and guided AI use. PHOENIX,...
AIAS+ 2026 Brings Leading Scientists to San Francisco to Explore How AI Is Changing Scientific Discovery
Chen Institute symposium Nov. 5–7 will feature newly named 2026 Nobel Laureate Karl Deisseroth alongside Terence Tao, Jeffrey Ullman, James...
Cala Announces Nationwide Launch of its Next Generation TAPS Therapy Wearable for Essential Tremor and Parkinson’s Disease Further Optimizing Meaningful Outcomes for More Patients
The Cala kIQ Plus System, cleared by FDA earlier this year, is the first and only wearable neuromodulation device for...
GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure TEMPE, Ariz., Oct. 6, 2026 /PRNewswire/ -- GT...
AIRS Medical Receives FDA 510(k) Clearance for SwiftSight® Body Composition
AI-powered quantitative MRI solution enables imaging organizations to standardize body composition analysis, expand existing MRI services and create new revenue...
AIRS Medical Receives FDA 510(k) Clearance for SwiftSight® Body Composition
AI-powered quantitative MRI solution enables imaging organizations to standardize body composition analysis, expand existing MRI services and create new revenue...
Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue
Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance PeriodBEIJING, Oct....